Form 4: Aadi Bioscience Director Receives Stock Grant
Insider Transaction (Form 4)
Anupam Dalal, a Director of Aadi Bioscience, Inc., reported multiple transactions in common stock on May 14, 2026.
Summary
- Grant/award: acquired 1,275,510 Common Stock at $3.92 ($4,999,999) on May 14, 2026; holds 4,685,912 after (Indirect).
- Grant/award: acquired 38,040 Stock Option (right to buy) on June 12, 2026; holds 38,040 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Anupam Dalal — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-05-14 | Grant/award | Common Stock | 1,275,510 | $4 | $5.0M | 4,685,912 |
| 2026-06-12 | Grant/award | Stock Option (right to buy) | 38,040 | — | — | 38,040 |
Key Dates
| Date | Description |
|---|---|
| 2026-05-14 | Grant/award (1,275,510 shares) |
| 2026-06-12 | Grant/award (38,040 shares) |
Keywords
insider transaction, Form 4, WHWK, Whitehawk Therapeutics, Inc., neutral, Anupam Dalal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.